Creating value across the entire product life cycle
Complete range of best-in-class strategic services
We create value across the product life cycle, from pre-clinical stages, through phases I, II and III, to launch and beyond, and right up to LoE. Our complete range of best-in-class services are built on the bedrock of our long-established and superior competitive intelligence capabilities.
From new product launches to label extensions, our comprehensive launch optimisation expertise considers how all external environmental factors can be taken into account to make your launch plan more effective.
It is absolutely vital to understand how competitors will seek to impede your launch and shape your market, especially by influencing key stakeholders, to create an unfavourable launch environment. Deallus excels at integrating the external competitive environment into your plan to strengthen working assumptions and provide increased confidence for a clearer path forward.
Launch optimisation related insight
Opportunity and Threat Assessment
As markets become ever more complex and competition increases, the ability to properly assess opportunities and threats by truly understanding and exploiting the strategic intent of competitors is becoming more important than ever.
The service provided by Deallus strengthens your competitive strategy by revealing the hidden opportunities that exist behind market threats.
Opportunity and threat assessment related insight
Our competitive readiness capabilities have established Deallus as a trusted partner to many of the world’s leading life sciences companies.
Our capability-building, based on the compelling competitor and market insights we unearth, underpins client strategic decision-making, reinforces competitive mindsets and strengthens brand planning processes to enhance competitive readiness across all relevant divisions, functions and geographies.
Asset and Portfolio Management
Deallus’ comprehensive and in-depth approach to competitive asset and portfolio lifecycle management delivers the assurance you need to make the right decisions for your NME, acquired asset, or even for an entire portfolio or business unit.
By offering reliable and resourceful analytics on a wide range of interrelated issues, including R&D activities, in-licensing and M&A, therapeutic area targeting, portfolio and indication prioritisation, lifecycle and LoE planning, and more, Deallus partners with our clients to achieve optimised value for your investments and astute ROI insights to support and maximise the performance of commercial portfolios.
Asset and portfolio management related insight
Brand Decision Making
When operating in markets that are especially complicated or where competition is fierce, there is often a need to go beyond our Opportunity and Threat Assessment and explore core market dynamics to the deepest extent possible.
This allows the right brand decisions, in terms of brand and portfolio positioning, distinct and sustainable promotional strategy and messaging, and distinctive value propositions, to be made.
Brand decision making related insight
Our proven methodologies for analysing a broad spectrum of drivers helps safeguard the commercial effectiveness of your organisation against constantly evolving and ever-changing competitive market challenges.
Our class-leading expertise in analysing internal organisational and external market environments will help ensure your organisation is fit and healthy to meet any future strategic challenges.
“Deallus was appointed to help us create a market access strategy when we were planning to enter a number of key emerging markets. The insights and analysis they provided equipped us with an in-depth understanding of the competitive landscape, key stakeholders, pricing and patient flow. On top of this they conceived an invaluable strategic roadmap for entry into each market. Deallus’ contribution was certainly outstanding as they helped us successfully drive access and uptake globally.”
Director of Global Market Access, Top 20 pharma brand